Drugs the Brain and Behavior 3rd Edition
By Meyer Nursing, Verified Chapters 1 - 20
WWW.THENURSINGMASTERY.COM
Page 1 of 247
,Chapter 1. Principles of Pharmacology
Chapter 2. Structure and Function of the Nervous System
Chapter 3. Chemical Signaling by Neurotransmitters and Hormones
Chapter 4. Methods of Research in Psychopharmacology
Chapter 5. Catecholamines
Chapter 6. Serotonin
Chapter 7. Acetylcholine
Chapter 8. Glutamate and GABA
Chapter 9. Drug Abuse and Addiction
Chapter 10. Alcohol
Chapter 11. The Opioids
Chapter 12. Psychomotor Stimulants: Cocaine, Amphetamine, and Related Drugs
Chapter 13. Nicotine and Caffeine
Chapter 14. Marijuana and the Cannabinoids
Chapter 15. Hallucinogens, PCP, and Ketamine
Chapter 16. Inhalants, GHB, and Anabolic-Androgenic Steroids
Chapter 17. Disorders of Anxiety and Impulsivity and the Drugs Used to Treat These
Disorders
Chapter 18. Affective Disorders: Antidepressants and Mood Stabilizers
Chapter 19. Schizophrenia: Antipsychotic Drugs
Chapter 20. Neurodegenerative Diseases
WWW.THENURSINGMASTERY.COM
Page 2 of 247
, Chapter 1: Principles of Pharmacology
Multiple Choice
1. refer(s) to specific molecular changes that occur when a drug binds to a
particular target site or receptor, while are the resulting widespread alterations
in function.
a. Drug action; therapeutic effects
b. Side effects; drug effects
c. Therapeutic effects; side effects
d. Drug action; drug effects
ANSWER: d
Textbook Reference: Pharmacology: The Science of Drug Action
2. After drug administration has occurred, the amount of drug in the blood that is free to
bind at specific target sites is referred to as
a. the therapeutic dose.
b. first-pass effects.
c. bioavailability.
d. ED50.
ANSWER: c
Textbook Reference: Pharmacokinetic Factors Determining Drug Action
3. The specific molecular changes that occur when a drug binds to a particular target site
or receptor are referred to as
a. drug effects.
b. drug action.
c. side effects.
d. placebo effects.
WWW.THENURSINGMASTERY.COM
Page 3 of 247
, ANSWER: b
Textbook vReference: vPharmacology: vThe vScience vof vDrug vAction
4. Which vof vthe vfollowing vis vnot va vpossible vexplanation vfor vplacebo veffects?
a. Pavlovian vconditioning
b. Genetic vvariation
c. Drug vcompetition
d. Expectation vof voutcome
ANSWER: vc
Textbook vReference: vPharmacology: vThe vScience vof vDrug vAction
5. The administration vof voxytocin vhas vbeen vproposed vas va vtreatment vfor
vautism.
a. intravenous
b. oral
c. intranasal
d. intracerebral
ANSWER: vc
Textbook vReference: vPharmacokinetic vFactors vDetermining vDrug vAction
6. Which vfactor vdoes vnot vaffect vthe vpharmacokinetics vof va vdrug?
a. Route vof vadministration
b. Lipid vsolubility
c. Depot vbinding
d. Drug vaction
ANSWER: vd
Textbook vReference: vPharmacokinetic vFactors vDetermining vDrug vAction
7. First-pass vmetabolism voccurs vwhen vdrugs vare vtaken
a. orally.
b. intravenously.
c. subcutaneously.
d. nasally.
WWW.THENURSINGMASTERY.COM
Page 4 of 247